Concepedia
Statistics
Publications
11
Citations
400
H-Index
Active since
2005
Affiliations
Experimental Drug Development Centre(Current)
Massachusetts Institute of Technology
Agency for Science, Technology and Research
Harvard–MIT Division of Health Sciences and Technology
Nanyang Technological University
Xiaoying Koh is an author at Experimental Drug Development Centre specializing in medicine, virology, and vaccination.
Top concepts
MedicineVirologyImmunologyVaccinationPharmacologyNatural SciencesViral PathogenesisAllergyPhysicsCovid-19
Publications per year
2005–2022
Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide
Bee Hui Liu, Chacko Jobichen, C. S. Brian Chia et al. · Proceedings of the National Academy of Sciences · 2018 · 68 citations · Full text
Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N<sup>1</sup>G37) Methyltransferase (TrmD) Inhibitors
Wenhe Zhong, Ann Koay, Anna Ngo et al. · ACS Infectious Diseases · 2019 · 53 citations · Full text
A 3D Monte Carlo Analysis of the Role of Dyadic Space Geometry in Spark Generation
Xiaoying Koh, Bhuvan Srinivasan, Andre Levchenko · Biophysical Journal · 2005 · 48 citations · Full text
Dyadic Space Geometry, Physics, Monte Carlo Analysis +5
Determinants of Glycan Receptor Specificity of H2N2 Influenza A Virus Hemagglutinin
Karthik Viswanathan, Xiaoying Koh, Aarthi Chandrasekaran et al. · PLoS ONE · 2010 · 41 citations · Full text
Vaccination, Virus Structure, Surface Glycoprotein Ha +11
A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
Subramanyam Vankadara, Monique Danielle Dawson, Jia Yi Fong et al. · ACS Medicinal Chemistry Letters · 2022 · 40 citations · Full text
Protease Inhibitors, Antiviral Compound, Nirmatrelvir Analogs +14
1–5 of 11